Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na(+)/I(−) Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin. Patients with advanced thyroid cancer do not benefit from radioiodine therapy due to reduced or absent NIS expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakshmanan, Aparna, Scarberry, Daniel, Green, Jill A., Zhang, Xiaoli, Selmi-Ruby, Samia, Jhiang, Sissy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741640/
https://www.ncbi.nlm.nih.gov/pubmed/26397139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741640/
https://www.ncbi.nlm.nih.gov/pubmed/26397139

Ejemplares similares